Effective for dates of service on or after January 1, 2018, the Centers for Medicare and Medicaid Services (CMS) has granted MYLOTARG™ (gemtuzumab ozogamicin) injection for IV infusion the following permanent Healthcare Common Procedure Coding System (HCPCS) J-Code*:

 J9203 – injection, gemtuzumab ozogamicin, 0.1 mg

We are respectfully requesting that you update your membership of this important coding change for MYLOTARG.   Additionally, patients receiving MYLOTARG, and their providers, have access to Pfizer Oncology Together, a program that provides support to help patients get their medication, including financial assistance, treatment support, and resources to navigate potential insurance and coverage issues. Resources are available by calling 1-877-744-5675 or at

Full Prescribing Information for MYLOTARG:

No comments have been posted yet.